BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guglielmi A, Ruzzenente A, Campagnaro T, Pachera S, Conci S, Valdegamberi A, Sandri M, Iacono C. Prognostic significance of lymph node ratio after resection of peri-hilar cholangiocarcinoma. HPB (Oxford). 2011;13:240-245. [PMID: 21418129 DOI: 10.1111/j.1477-2574.2010.00277.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 3.9] [Reference Citation Analysis]
Number Citing Articles
1 Gao Y, Xu D, Wu YS, Chen D, Xiong W. Increasing negative lymph node count is independently associated with improved long-term survival in resectable perihilar cholangiocarcinomas. Medicine (Baltimore) 2019;98:e14943. [PMID: 30985643 DOI: 10.1097/MD.0000000000014943] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Kambakamba P, Linecker M, Slankamenac K, DeOliveira ML. Lymph node dissection in resectable perihilar cholangiocarcinoma: a systematic review. Am J Surg. 2015;210:694-701. [PMID: 26212390 DOI: 10.1016/j.amjsurg.2015.05.015] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
3 Brandi G, Tavolari S, Biasco G. Genomic and Genetic Characterization of Cholangiocarcinoma Identifies Therapeutics Targets for Tyrosine Kinase Inhibitors. Gastroenterology 2012;143:e20-1. [DOI: 10.1053/j.gastro.2012.07.120] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
4 Dumitrascu T, Chirita D, Ionescu M, Popescu I. Resection for hilar cholangiocarcinoma: analysis of prognostic factors and the impact of systemic inflammation on long-term outcome. J Gastrointest Surg. 2013;17:913-924. [PMID: 23319395 DOI: 10.1007/s11605-013-2144-2] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 6.5] [Reference Citation Analysis]
5 Atanasov G, Hau HM, Dietel C, Benzing C, Krenzien F, Brandl A, Wiltberger G, Matia I, Prager I, Schierle K. Prognostic significance of macrophage invasion in hilar cholangiocarcinoma. BMC Cancer. 2015;15:790. [PMID: 26497197 DOI: 10.1186/s12885-015-1795-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
6 Lin H, Wu YS, Li Z, Jiang Y. Prognostic value of retrieved lymph node counts in patients with node-negative perihilar cholangiocarcinomas. ANZ J Surg 2018;88:E829-34. [PMID: 30207026 DOI: 10.1111/ans.14775] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Mao K, Liu J, Sun J, Zhang J, Chen J, Pawlik TM, Jacobs LK, Xiao Z, Wang J. Patterns and prognostic value of lymph node dissection for resected perihilar cholangiocarcinoma. J Gastroenterol Hepatol. 2016;31:417-426. [PMID: 26250532 DOI: 10.1111/jgh.13072] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
8 Benzing C, Krenzien F, Mieg A, Wolfsberger A, Andreou A, Nevermann N, Pelzer U, Fehrenbach U, Haiden LM, Öllinger R, Schöning W, Schmelzle M, Pratschke J. A tailored approach in lymph node-positive perihilar cholangiocarcinoma. Langenbecks Arch Surg 2021;406:1499-509. [PMID: 34075473 DOI: 10.1007/s00423-021-02154-4] [Reference Citation Analysis]
9 Conci S, Ruzzenente A, Sandri M, Bertuzzo F, Campagnaro T, Bagante F, Capelli P, D'Onofrio M, Piccino M, Dorna AE, Pedrazzani C, Iacono C, Guglielmi A. What is the most accurate lymph node staging method for perihilar cholangiocarcinoma? Comparison of UICC/AJCC pN stage, number of metastatic lymph nodes, lymph node ratio, and log odds of metastatic lymph nodes. Eur J Surg Oncol. 2017;43:743-750. [PMID: 28094085 DOI: 10.1016/j.ejso.2016.12.007] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 6.5] [Reference Citation Analysis]
10 Zhao J, Zhang W, Zhang J, Ma WJ, Liu SY, Li FY, Song B. External validation study of the 8th edition of the American Joint Committee on Cancer staging system for perihilar cholangiocarcinoma: a single-center experience in China and proposal for simplification. J Gastrointest Oncol 2021;12:806-18. [PMID: 34012668 DOI: 10.21037/jgo-20-348] [Reference Citation Analysis]
11 Berardi R, Mocchegiani F, Pierantoni C, Federici A, Nicolini D, Morgese F, Onofri A, Risaliti A, Vivarelli M, Cascinu S. Resected biliary tract cancers: a novel clinical-pathological score correlates with global outcome. Dig Liver Dis 2013;45:70-4. [PMID: 22999058 DOI: 10.1016/j.dld.2012.08.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
12 Kim BH, Kim K, Chie EK, Kwon J, Jang J, Kim SW, Han S, Oh D, Im S, Kim T, Bang Y, Ha SW. The Prognostic Importance of the Number of Metastatic Lymph Nodes for Patients Undergoing Curative Resection Followed by Adjuvant Chemoradiotherapy for Extrahepatic Bile Duct Cancer. J Gastrointest Surg 2015;19:1833-41. [DOI: 10.1007/s11605-015-2898-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
13 Ruzzenente A, Bagante F, Ardito F, Campagnaro T, Scoleri I, Conci S, Iacono C, Giuliante F, Guglielmi A. Comparison of the 7th and 8th editions of the American Joint Committee on Cancer Staging Systems for perihilar cholangiocarcinoma. Surgery. 2018;164:244-250. [PMID: 29801730 DOI: 10.1016/j.surg.2018.03.012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
14 Lee JW, Lee JH, Park Y, Lee W, Kwon J, Song KB, Hwang DW, Kim SC. Prognostic Predictability of American Joint Committee on Cancer 8th Staging System for Perihilar Cholangiocarcinoma: Limited Improvement Compared with the 7th Staging System. Cancer Res Treat 2020;52:886-95. [PMID: 32164049 DOI: 10.4143/crt.2020.023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
15 Lauterio A, De Carlis R, Centonze L, Buscemi V, Incarbone N, Vella I, De Carlis L. Current Surgical Management of Peri-Hilar and Intra-Hepatic Cholangiocarcinoma. Cancers (Basel) 2021;13:3657. [PMID: 34359560 DOI: 10.3390/cancers13153657] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Guglielmi A, Ruzzenente A, Bertuzzo F, Iacono C. Assessment of nodal status for perihilar cholangiocarcinoma location, number, or ratio of involved nodes. Hepatobiliary Surg Nutr 2013;2:281-3. [PMID: 24570959 DOI: 10.3978/j.issn.2304-3881.2013.08.10] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
17 Zhao J, Zhang W, Zhang J, Zhang Y, Ma WJ, Liu SY, Li FY, Song B. Survival analysis of patients with stage T2a and T2b perihilar cholangiocarcinoma treated with radical resection. BMC Cancer 2020;20:849. [PMID: 32883228 DOI: 10.1186/s12885-020-07357-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
18 Cereda S, Belli C, Reni M. Adjuvant treatment in biliary tract cancer: To treat or not to treat? World J Gastroenterol 2012; 18(21): 2591-2596 [PMID: 22690066 DOI: 10.3748/wjg.v18.i21.2591] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
19 Zou W, Zhu C, Wang Z, Tan X, Li C, Zhao Z, Hu M, Liu R. A Novel Nomogram Based on Log Odds of Metastatic Lymph Nodes to Predict Overall Survival in Patients With Perihilar Cholangiocarcinoma After Surgery. Front Oncol 2021;11:649699. [PMID: 34367951 DOI: 10.3389/fonc.2021.649699] [Reference Citation Analysis]
20 Soares KC, Kamel I, Cosgrove DP, Herman JM, Pawlik TM. Hilar cholangiocarcinoma: diagnosis, treatment options, and management. Hepatobiliary Surg Nutr. 2014;3:18-34. [PMID: 24696835 DOI: 10.3978/j.issn.2304-3881.2014.02.05] [Cited by in F6Publishing: 45] [Reference Citation Analysis]
21 Tang Z, Yang Y, Zhao Z, Wei K, Meng W, Li X. The clinicopathological factors associated with prognosis of patients with resectable perihilar cholangiocarcinoma: A systematic review and meta-analysis. Medicine (Baltimore) 2018;97:e11999. [PMID: 30142840 DOI: 10.1097/MD.0000000000011999] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
22 Kambakamba P, Deoliveira ML. Perihilar cholangiocarcinoma: paradigms of surgical management. The American Journal of Surgery 2014;208:563-70. [DOI: 10.1016/j.amjsurg.2014.05.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
23 Guglielmi A, Ruzzenente A, Valdegamberi A, Bagante F, Conci S, Pinna AD, Ercolani G, Giuliante F, Capussotti L, Aldrighetti L. Hepatolithiasis-associated cholangiocarcinoma: results from a multi-institutional national database on a case series of 23 patients. Eur J Surg Oncol. 2014;40:567-575. [PMID: 24388409 DOI: 10.1016/j.ejso.2013.12.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
24 Popescu I, Dumitrascu T. Curative-intent surgery for hilar cholangiocarcinoma: prognostic factors for clinical decision making. Langenbecks Arch Surg 2014;399:693-705. [PMID: 24841192 DOI: 10.1007/s00423-014-1210-x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 4.4] [Reference Citation Analysis]
25 Aoba T, Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y, Nimura Y, Nagino M. Assessment of nodal status for perihilar cholangiocarcinoma: location, number, or ratio of involved nodes. Ann Surg. 2013;257:718-725. [PMID: 23407295 DOI: 10.1097/sla.0b013e3182822277] [Cited by in Crossref: 85] [Cited by in F6Publishing: 28] [Article Influence: 10.6] [Reference Citation Analysis]
26 Hakeem AR, Marangoni G, Chapman SJ, Young RS, Nair A, Hidalgo EL, Toogood GJ, Wyatt JI, Lodge PA, Prasad KR. Does the extent of lymphadenectomy, number of lymph nodes, positive lymph node ratio and neutrophil-lymphocyte ratio impact surgical outcome of perihilar cholangiocarcinoma? Eur J Gastroenterol Hepatol. 2014;26:1047-1054. [PMID: 25051217 DOI: 10.1097/meg.0000000000000162] [Cited by in Crossref: 29] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
27 Ma WJ, Wu ZR, Hu HJ, Wang JK, Yin CH, Shi YJ, Li FY, Cheng NS. Extended Lymphadenectomy Versus Regional Lymphadenectomy in Resectable Hilar Cholangiocarcinoma. J Gastrointest Surg. 2019;Online ahead of print. [PMID: 31147975 DOI: 10.1007/s11605-019-04244-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
28 Guglielmi A, Ruzzenente A, Campagnaro T, Valdegamberi A, Bagante F, Bertuzzo F, Conci S, Iacono C. Patterns and Prognostic Significance of Lymph Node Dissection for Surgical Treatment of Perihilar and Intrahepatic Cholangiocarcinoma. J Gastrointest Surg 2013;17:1917-28. [DOI: 10.1007/s11605-013-2331-1] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 7.0] [Reference Citation Analysis]
29 Li J, Zhou MH, Ma WJ, Li FY, Deng YL. Extended lymphadenectomy in hilar cholangiocarcinoma: What it will bring? World J Gastroenterol 2020; 26(24): 3318-3325 [PMID: 32655260 DOI: 10.3748/wjg.v26.i24.3318] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Wirasorn K, Ngamprasertchai T, Chindaprasirt J, Sookprasert A, Khantikaew N, Pakkhem A, Ungarereevittaya P. Prognostic factors in resectable cholangiocarcinoma patients: Carcinoembryonic antigen, lymph node, surgical margin and chemotherapy. World J Gastrointest Oncol 2013; 5(4): 81-87 [PMID: 23671735 DOI: 10.4251/wjgo.v5.i4.81] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
31 Nari GA, Palacios OG, Lopez-ben S, Albiol M, Falgueras L, Castro-gutierrez E, Figueras J. Colangiocarcinoma hiliar: el número de ganglios positivos y la relación ganglios positivos/ganglios totales son un factor pronóstico importante de supervivencia. Cirugía Española 2014;92:247-53. [DOI: 10.1016/j.ciresp.2013.07.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
32 Sakata J, Wakai T, Matsuda Y, Ohashi T, Hirose Y, Ichikawa H, Kobayashi T, Minagawa M, Kosugi S, Koyama Y, Akazawa K, Ajioka Y. Comparison of Number Versus Ratio of Positive Lymph Nodes in the Assessment of Lymph Node Status in Extrahepatic Cholangiocarcinoma. Ann Surg Oncol. 2016;23:225-234. [PMID: 25994208 DOI: 10.1245/s10434-015-4609-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
33 Li B, Xiong XZ, Zhou Y, Wu SJ, You Z, Lu J, Cheng NS. Prognostic value of lymphovascular invasion in Bismuth-Corlette type IV hilar cholangiocarcinoma. World J Gastroenterol 2017; 23(36): 6685-6693 [PMID: 29085213 DOI: 10.3748/wjg.v23.i36.6685] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
34 Abe T, Amano H, Shimamoto F, Hattori M, Kuroda S, Kobayashi T, Tashiro H, Ohdan H. Prognostic evaluation of mucin-5AC expression in intrahepatic cholangiocarcinoma, mass-forming type, following hepatectomy. European Journal of Surgical Oncology (EJSO) 2015;41:1515-21. [DOI: 10.1016/j.ejso.2015.07.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
35 Ratti F, Cipriani F, Ariotti R, Gagliano A, Paganelli M, Catena M, Aldrighetti L. Safety and feasibility of laparoscopic liver resection with associated lymphadenectomy for intrahepatic cholangiocarcinoma: a propensity score-based case-matched analysis from a single institution. Surg Endosc 2016;30:1999-2010. [DOI: 10.1007/s00464-015-4430-4] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 7.2] [Reference Citation Analysis]